Sunscreens in human plasma and urine after repeated whole-body topical application

Journal of the European Academy of Dermatology and Venereology

Volumn 22, Issue 4, 2008, Pages 456-461

  Janjua, N R ^a   Kongshoj, B ^a   Andersson, A M ^b   Wulf, H C ^a  

^a BISPEBJERG HOSPITAL   (Denmark)

^b International Center for Research and Research Training in Endocrine Disruption of Male Reproduction and Child Health   (Denmark)

Author keywords

3 (4 metylbenzylidene)camphor; 4 MBC; Benzophenone 3; BP 3; Octyl methoxycinnamate; OMC; Plasma levels; Postmenopausal women; Sunscreens; Systemic absorption; Urine excretion; Whole body topical application; Young men

Indexed keywords

3 (4 METHYLBENZYLIDENE)CAMPHOR; 4 METHOXYCINNAMIC ACID 2 ETHYLHEXYL ESTER; ESCALOL 557; EUSOLEX 4360; OXYBENZONE; SUNSCREEN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG EXCRETION; DRUG FORMULATION; DRUG UPTAKE; DRUG URINE LEVEL; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN EXPERIMENT; MALE; NORMAL HUMAN; PRIORITY JOURNAL; URINALYSIS; URINARY EXCRETION;

ADMINISTRATION, TOPICAL; ADULT; AGED; AGED, 80 AND OVER; BENZOPHENONES; CAMPHOR; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CINNAMATES; FEMALE; HUMANS; MALE; MIDDLE AGED; POSTMENOPAUSE; SKIN ABSORPTION; STATISTICS, NONPARAMETRIC; SUNSCREENING AGENTS;

EID: 41149091271     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2007.02492.x     Document Type: Article

References (22)

1. Gonzalez HG, Farbrot A, Larko O. Percutaneous absorption of benzophenone-3, a common component of topical sunscreens. Clin Exp Dermatol 2002; 27: 691-694.
2. Gonzalez H, Farbrot A, Larko O, Wennberg AM. Percutaneous absorption of the sunscreen benzophenone-3 after repeated whole-body applications, with and without ultraviolet irradiation. Br J Dermatol 2006; 154: 337-340.
3. Schauer UMD, Volkel W, Heusener A et al. Kinetics of 3-(4-methylbenzylidene) camphor in rats and humans after dermal application. Toxicol Appl Pharmacol 2006; 216: 339-346.
4. Sarveiya V, Risk S, Benson HA. Liquid chromatographic assay for common sunscreen agents: Application to in vivo assessment of skin penetration and systemic absorption in human volunteers. J Chromatogr B Anal Technol Biomed Life Sci 2004; 803: 225-231.
5. Janjua NR, Mogensen B, Andersson AM et al. Systemic absorption of the sunscreens benzophenone-3, octyl-methoxycinnamate, and 3-(4-methyl-benzylidene) camphor after whole-body topical application and reproductive hormone levels in humans. J Invest Dermatol, 2004; 123: 57-61.
6. Dubois D, Dubois EF. Nutrition metabolism classic - a formula to estimate the approximate surface-area if height and weight be known (Reprinted from Archives Internal Medicine, Vol 17, pg 863, 1916). Nutrition 1989; 5: 303-311.
7. Gagliardi L, Amato A, Basili A, Cavazzutti G, Tonelli D. Determination of Sun-Screen Agents in Cosmetic Products by Reversed-Phase High-Performance Liquid-Chromatography. J Chromatogr 1987; 408: 409-415.
8. Lowe NJ. Photoprotection. In: Hawk JLM ed. Photodermatology. Chapman & Hall, London, 1998: 213-221.
9. Hayden CGJ, Roberts MS, Benson HAE. Systemic absorption of sunscreen after topical application. Lancet 1997; 350: 863-864.
10. Hagedornleweke U, Lippold BC. Absorption of sunscreens and other compounds through human skin in-vivo - derivation of a method to predict maximum fluxes. Pharmaceut Res 1995; 12: 1354-1360.
11. Okereke CS, Abdelrahman MS, Friedman MA. Disposition of Benzophenone-3 After Dermal Administration in Male-Rats. Toxicol Lett 1994; 73: 113-122.
12. Schwartz JB. The influence of sex on pharmacokinetics, vol 42, pg 107, 2003). Clin Pharmacokinetics 2004; 43: 732.
13. Cusack B, Evestal R. Pharmacology. In: The Merck Manual of Geriatrics. Merck & Company, 3rd edn. 2000: 54-74.
14. Benowitz NL. Clinical-pharmacology of nicotine. Annu Rev Med 1986; 37: 21-32.
15. Paluska SA. Caffeine and exercise. Curr Sports Med 2003; 2: 213-219.
16. Shirreffs SM, Maughan RJ. The effect of alcohol on athletic performance. Curr Sports Med 2006; 5: 192-196.
17. Lenz TL, Lenz NJ, Faulkner MA. Potential interactions between exercise and drug therapy. Sports Med 2004; 34: 293-306.
18. Tarras-Wahlberg N, Stenhagen G, Larko O et al. Changes in ultraviolet absorption of sunscreens after ultraviolet irradiation. J Invest Dermatol 1999; 113: 547-553.
19. Volkel W, Colnot T, Schauer UMD, Broschard TH, Dekant W. Toxicokinetics and biotransformation of 3-(4-methylbenzylidene) camphor in rats after oral administration. Toxicol Appl Pharmacol 2006; 216: 331-338.
20. Benedetti MS, Baltes EL. Drug metabolism and disposition in children. Fundamental Clin Pharmacol 2003; 17: 281-299.
21. Ginsberg G, Hattis D, Sonawane B. Incorporating pharmacokinetic differences between children and adults in assessing children's risks to environmental toxicants. Toxicol Appl Pharmacol 2004; 198: 164-183.
22. Strassburg CP, Strassburg A, Kneip S et al. Developmental aspects of human hepatic drug glucuronidation in young children and adults. Gut, 2002; 50: 259-265.